13 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 13 of 13 clinical reviews.
Secondary hypogonadism frequently co-occurs with depression, anxiety, and cognitive decline. Learn how hypothalamic-pituitary dysfunction links low testosterone to mental health conditions, and what evidence-based treatments can help.
A step-by-step diagnostic algorithm for secondary hypogonadism, covering morning testosterone testing, LH/FSH interpretation, pituitary imaging, and when to refer, grounded in Endocrine Society and AUA guidelines.
A guide to exercise protocols for secondary hypogonadism, covering resistance training, HIIT, aerobic work, and how structured movement affects LH, FSH, and testosterone recovery.
A side-by-side comparison of major society guidelines for diagnosing and treating secondary hypogonadism, including diagnostic thresholds, treatment algorithms, and fertility-preserving options.
How secondary hypogonadism presents and is managed in obesity, type 2 diabetes, opioid use, HIV, CKD, and other special populations. Evidence-based guidance from the Endocrine Society, ADA, and AACE.
Evidence-based monitoring schedule for secondary hypogonadism, including lab timing, hormone targets, and follow-up intervals from the Endocrine Society, AUA, and AACE guidelines.
Secondary hypogonadism carries measurable economic costs through lost wages, healthcare utilization, and long-term comorbidities. This evidence-based review covers the financial burden on patients, payers, and society, and flags where precise figures require independent verification.
Evidence-based treatment algorithm for secondary hypogonadism, organized by line of therapy. Covers lifestyle modification, clomiphene, enclomiphene, hCG, and testosterone replacement, with attention to what is guideline-supported versus what still needs verification.
A guide for caregivers and family members supporting someone with secondary hypogonadism, covering diagnosis, treatment options, emotional support strategies, and clinical resources.
A guide to secondary hypogonadism comorbidities, including type 2 diabetes, obesity, sleep apnea, hyperprolactinemia, and opioid use, with diagnostic criteria, treatment options, and Endocrine Society guideline references.
Secondary hypogonadism is frequently overlooked or confused with primary testicular failure, depression, or aging. Learn the red-flag lab patterns, commonly missed causes, and fertility-preserving treatment options including enclomiphene and hCG.
A clinical review of the latest trials, investigational therapies, and guideline updates reshaping how secondary hypogonadism is diagnosed and treated, including oral enclomiphene, kisspeptin agonists, and selective androgen receptor modulators.
How inherited gene variants and familial patterns contribute to secondary hypogonadism, what genetic tests are available, and when clinicians should suspect a hereditary cause.